Zhou Xing, professor of medicine and member of the Michael G. DeGroote Institute for Infectious Disease Research, is being honoured for his renowned immunology research program, which focuses on respiratory mucosal immunity, infectious diseases and vaccine development.
The inhaled aerosol vaccine is far more effective at inducing protective immune responses than traditional injections, targeting the lungs and upper airways where viruses first enter the body and providing long-lasting protection against respiratory infections.
McMaster scientists found a common tuberculosis vaccine triggers an immune-communicating mechanism from the gut that offers broad protection against respiratory pathogens in the lung.